ClearPoint Neuro (CLPT) Revenue & Revenue Breakdown

OverviewOwnership Financials Chart Transcripts

ClearPoint Neuro Revenue Highlights

Latest Revenue (Y)

$31.39M

Latest Revenue (Q)

$7.77M

Main Segment (Y)

Biologics and Drug Delivery Revenue

ClearPoint Neuro Revenue by Period

ClearPoint Neuro Revenue by Year

Date	Revenue	Change
2024-12-31	$31.39M	31.04%
2023-12-31	$23.95M	16.56%
2022-12-31	$20.55M	26.09%
2021-12-31	$16.30M	27.05%
2020-12-31	$12.83M	14.37%
2019-12-31	$11.22M	52.54%
2018-12-31	$7.35M	-0.36%
2017-12-31	$7.38M	28.35%
2016-12-31	$5.75M	25.15%
2015-12-31	$4.59M	27.46%
2014-12-31	$3.60M	-8.30%
2013-12-31	$3.93M	-22.29%
2012-12-31	$5.06M	32.48%
2011-12-31	$3.82M	43.03%
2010-12-31	$2.67M	-

ClearPoint Neuro generated $31.39M in revenue during NA 2024, up 31.04% compared to the previous quarter, and up 279.84% compared to the same period a year ago.

ClearPoint Neuro Revenue by Quarter

Date	Revenue	Change
2024-12-31	$7.77M	-4.32%
2024-09-30	$8.12M	3.36%
2024-06-30	$7.86M	2.87%
2024-03-31	$7.64M	12.17%
2023-12-31	$6.81M	18.19%
2023-09-30	$5.76M	-3.16%
2023-06-30	$5.95M	9.52%
2023-03-31	$5.43M	5.01%
2022-12-31	$5.17M	0.54%
2022-09-30	$5.15M	-1.04%
2022-06-30	$5.20M	3.36%
2022-03-31	$5.03M	17.49%
2021-12-31	$4.28M	-6.38%
2021-09-30	$4.57M	34.02%
2021-06-30	$3.41M	-15.31%
2021-03-31	$4.03M	8.45%
2020-12-31	$3.72M	5.59%
2020-09-30	$3.52M	42.03%
2020-06-30	$2.48M	-20.47%
2020-03-31	$3.12M	-2.96%
2019-12-31	$3.21M	9.67%
2019-09-30	$2.93M	12.32%
2019-06-30	$2.61M	5.41%
2019-03-31	$2.47M	8.61%
2018-12-31	$2.28M	25.98%
2018-09-30	$1.81M	9.76%
2018-06-30	$1.65M	1.41%
2018-03-31	$1.62M	-3.34%
2017-12-31	$1.68M	-2.20%
2017-09-30	$1.72M	-13.10%
2017-06-30	$1.98M	-1.55%
2017-03-31	$2.01M	22.75%
2016-12-31	$1.64M	1.16%
2016-09-30	$1.62M	46.42%
2016-06-30	$1.10M	-20.82%
2016-03-31	$1.39M	-7.77%
2015-12-31	$1.51M	21.28%
2015-09-30	$1.25M	50.95%
2015-06-30	$825.74K	-18.28%
2015-03-31	$1.01M	5.27%
2014-12-31	$959.84K	51.58%
2014-09-30	$633.20K	-46.74%
2014-06-30	$1.19M	44.54%
2014-03-31	$822.53K	-30.08%
2013-12-31	$1.18M	26.84%
2013-09-30	$927.46K	64.88%
2013-06-30	$562.49K	-55.51%
2013-03-31	$1.26M	-32.13%
2012-12-31	$1.86M	64.57%
2012-09-30	$1.13M	4.44%
2012-06-30	$1.08M	10.59%
2012-03-31	$980.00K	-15.82%
2011-12-31	$1.16M	0.80%
2011-09-30	$1.15M	59.76%
2011-06-30	$722.89K	-

ClearPoint Neuro generated $7.77M in revenue during Q4 2024, up -4.32% compared to the previous quarter, and up 134.87% compared to the same period a year ago.

ClearPoint Neuro Revenue Breakdown

ClearPoint Neuro Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Biologics and Drug Delivery Revenue	$17.31M	$13.60M	$9.12M	$6.79M	$5.04M
Capital Equipment and Software - Services	$1.06M	$973.00K	$795.00K	$569.00K	-
Biologics and Drug Delivery - Disposable Products	$5.61M	$2.15M	$3.69M	$3.35M	-
Capital Equipment and Software - Systems and Software Products	$2.73M	$860.00K	$1.51M	$864.00K	-
Capital Equipment and Software Revenue	$3.79M	$1.83M	$2.31M	$1.43M	$1.49M
Functional Neurosurgery Navigation and Therapy	-	$8.52M	$9.12M	$8.07M	-
Functional Neurosurgery Navigation and Therapy - Disposable Products	-	$7.59M	$7.59M	$7.70M	-
Functional Neurosurgery Navigation and Therapy - Services	-	$931.00K	$1.54M	$375.00K	-
Biologics and Drug Delivery - Services	-	-	-	$3.44M	-

ClearPoint Neuro's latest annual revenue breakdown by segment (product or service), as of Dec 24: Biologics and Drug Delivery Revenue (56.74%), Biologics and Drug Delivery - Disposable Products (18.38%), Capital Equipment and Software Revenue (12.44%), Capital Equipment and Software - Systems and Software Products (8.97%), and Capital Equipment and Software - Services (3.47%).

Quarterly Revenue by Product

Product/Service	Mar 25	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Biologics And Drug Delivery	$4.69M	$4.43M	$4.31M	$3.49M	$3.37M	$2.68M	$2.25M	$2.41M	$2.15M	$72.50K	-	-	-	-	-	-	-	-	-	-
Biologics And Drug Delivery - Disposable Products	$1.78M	$2.06M	$553.00K	$455.00K	$346.00K	$594.00K	$798.00K	$1.23M	$850.00K	-	-	-	-	-	-	-	-	-	-	-
Capital Equipment And Software	$517.00K	$831.00K	$1.41M	$357.00K	$381.00K	$396.00K	$480.00K	$619.00K	$639.00K	-	-	-	-	-	-	-	-	-	-	-
Capital Equipment And Software - Systems and Software Products	$234.00K	$552.00K	$1.16M	$81.00K	$173.00K	$178.00K	$287.00K	$434.00K	$450.00K	-	-	-	-	-	-	-	-	-	-	-
Capital Equipment And Software - Services	$283.00K	$279.00K	$250.00K	$276.00K	$208.00K	$218.00K	$193.00K	$185.00K	$189.00K	-	-	-	-	-	-	-	-	-	-	-
Functional Neurosurgery Navigation and Therapy - Services	-	-	-	$1.00K	$44.00K	$383.00K	$503.00K	$375.00K	$375.00K	$375.00K	-	-	-	-	-	-	-	-	-	-
Functional Neurosurgery Navigation and Therapy	-	-	$1.93M	$2.04M	$1.92M	$2.20M	$2.36M	$2.42M	$2.17M	$2.24M	$2.14M	-	-	-	-	-	-	-	-	-
Functional Neurosurgery Navigation and Therapy - Disposable Products	-	-	$1.93M	$2.04M	$1.87M	$1.82M	$1.86M	$2.04M	$1.80M	$1.86M	-	-	-	-	-	-	-	-	-	-
Biologics And Drug Delivery - Services	-	-	-	-	-	-	-	$1.45M	$1.18M	$1.30M	-	-	-	-	-	-	-	-	-	-
Capital Equipment and Software - Services	-	-	-	-	-	-	-	-	-	-	$170.00K	-	-	-	-	-	-	-	-	-
Biologics and Drug Delivery Revenue	-	-	-	-	-	-	-	-	-	-	$1.69M	$1.66M	-	-	-	-	-	-	-	-
Capital Equipment and Software - Systems and Software Products	-	-	-	-	-	-	-	-	-	-	$284.00K	-	-	-	-	-	-	-	-	-
Capital Equipment and Software Revenue	-	-	-	-	-	-	-	-	-	-	$454.00K	$453.00K	-	-	-	-	-	-	-	-
Biologics and Drug Delivery - Disposable Products	-	-	-	-	-	-	-	-	-	-	$852.00K	-	-	-	-	-	-	-	-	-
Biologics and Drug Delivery - Services	-	-	-	-	-	-	-	-	-	-	$837.00K	-	-	-	-	-	-	-	-	-
Remaining Performance Obligations Capital Equipment-Related Service Revenue	-	-	-	-	-	-	-	-	-	-	-	$800.00K	-	$-320.00K	$992.00K	-	-	-	-	-
Capital Equipment Related Service Revenue	-	-	-	-	-	-	-	-	-	-	-	$100.00K	$90.00K	-	-	-	-	-	-	-
Capital Equipment-Related Service Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$217.00K	$89.00K	$121.00K	-	-	-
Biologics and Drug Delivery Revenue Subtotal	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.47M	-	-	-	-
Capital Equipment and Software Revenue Subtotal	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$204.56K	-	-	-	-
Therapy Revenue Subtotal	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$103.80K	-	-	-	-
Product Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$2.52M	-
Service and Other Revenues	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$686.77K	$333.04K
Biologics and Drug Delivery	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$491.26K
Capital Equipment and Other	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$210.54K
Capital Equipment	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$184.82K
Functional Neurology	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.85M
Product Revenues	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$2.59M
Therapy	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$64.09K
Therapy1Member	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$50.00K

ClearPoint Neuro's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Biologics And Drug Delivery (62.50%), Biologics And Drug Delivery - Disposable Products (23.72%), Capital Equipment And Software (6.89%), Capital Equipment And Software - Services (3.77%), and Capital Equipment And Software - Systems and Software Products (3.12%).

ClearPoint Neuro Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
LIVN	LivaNova	$1.25B	$321.80M
INSP	Inspire Medical Systems	$802.80M	$201.32M
INGN	Inogen	$335.70M	$80.08M
TMCI	Treace Medical Concepts	$209.36M	$68.71M
KIDS	OrthoPediatrics	$204.73M	$52.67M
SRDX	Surmodics	$126.08M	$28.09M
OM	Outset Medical	$113.69M	$29.47M
LUNG	Pulmonx	$83.79M	$22.54M
NPCE	NeuroPace	$79.91M	$21.47M
SGHT	Sight Sciences	$79.87M	$19.07M
TELA	TELA Bio	$69.30M	$17.65M
RCEL	AVITA Medical	$50.56M	$18.41M
APYX	Apyx Medical	$48.10M	$14.22M
CLPT	ClearPoint Neuro	$31.39M	$7.77M
CTSO	Cytosorbents	$25.13M	$9.15M

CLPT Revenue FAQ

What is ClearPoint Neuro’s yearly revenue?

ClearPoint Neuro's yearly revenue for 2024 was $31.39M, representing an increase of 31.04% compared to 2023. The company's yearly revenue for 2023 was $23.96M, representing an increase of 16.56% compared to 2022. CLPT's yearly revenue for 2022 was $20.55M, representing an increase of 26.09% compared to 2021.

What is ClearPoint Neuro’s quarterly revenue?

ClearPoint Neuro's quarterly revenue for Q4 2024 was $7.77M, a -4.32% decrease from the previous quarter (Q3 2024), and a 14.11% increase year-over-year (Q4 2023). The company's quarterly revenue for Q3 2024 was $8.12M, a 3.36% increase from the previous quarter (Q2 2024), and a 40.96% increase year-over-year (Q3 2023). CLPT's quarterly revenue for Q2 2024 was $7.86M, a 2.87% increase from the previous quarter (Q1 2024), and a 32.07% increase year-over-year (Q2 2023).

What is ClearPoint Neuro’s revenue growth rate?

ClearPoint Neuro's revenue growth rate for the last 3 years (2022-2024) was 52.74%, and for the last 5 years (2020-2024) was 144.68%.

What are ClearPoint Neuro’s revenue streams?

ClearPoint Neuro's revenue streams in c 24 are Biologics and Drug Delivery Revenue, Capital Equipment and Software - Services, Biologics and Drug Delivery - Disposable Products, Capital Equipment and Software - Systems and Software Products, and Capital Equipment and Software Revenue. Biologics and Drug Delivery Revenue generated $17.31M in revenue, accounting 56.74% of the company's total revenue, up 27.26% year-over-year. Capital Equipment and Software - Services generated $1.06M in revenue, accounting 3.47% of the company's total revenue, up 8.94% year-over-year. Biologics and Drug Delivery - Disposable Products generated $5.61M in revenue, accounting 18.38% of the company's total revenue, up 160.26% year-over-year. Capital Equipment and Software - Systems and Software Products generated $2.74M in revenue, accounting 8.97% of the company's total revenue, up 218.02% year-over-year. Capital Equipment and Software Revenue generated $3.8M in revenue, accounting 12.44% of the company's total revenue, up 107.04% year-over-year.

What is ClearPoint Neuro’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of ClearPoint Neuro was Biologics and Drug Delivery Revenue. This segment made a revenue of $17.31M, representing 56.74% of the company's total revenue.